The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease

Overview of attention for article published in Current Alzheimer Research, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

patent: 9 patents

Readers on

mendeley: 63 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 756 followers.

The authors state "Additional systemic or extrahepatic metabolic effects of inhibition of Brd4-mediated transcription could also contribute to hyperglycemia induced by JQ-1." JQ1 probably gets into all major tissues! Even brain! Not just the intestine…

The BET-bromodomain inhibitor JQ1 reduces inflammation and tau phosphorylation at Ser396 in… https://t.co/xscYqwzstY

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.